VanEck Pharmaceutical ETF (PPH) Holdings
PPH holdings summary
as of Oct 25, 2026- Holdings
- 25 positions listed
- Top 10 weight
- 72.1% of net assets
- Effective holdings
- 11 equal-weight equivalent
- Largest holding
- LLY 21.83% Eli Lilly and Company
- Annual turnover
- 21.5% of the portfolio traded
All PPH holdings
| # | Name | ||||||
|---|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | Healthcare | 21.83% | $231.8M | $1.12T | 42.2 |
| 2 | MRK | Merck & Co., Inc. | Healthcare | 13.12% | $139.4M | $360.08B | 115.8 |
| 3 | NVO | Novo Nordisk A/S | Healthcare | 5.49% | $58.3M | $171.36B | 9.1 |
| 4 | PFE | Pfizer Inc. | Healthcare | 4.92% | $52.2M | $168.60B | 38.9 |
| 5 | MCK | McKesson Corporation | Healthcare | 4.82% | $51.1M | $117.15B | 26.9 |
| 6 | GSK | GSK plc | Healthcare | 4.68% | $49.7M | $99.19B | 15.6 |
| 7 | COR | Cencora | Healthcare | 4.49% | $47.7M | $65.06B | 25.3 |
| 8 | BMY | Bristol-Myers Squibb Company | Healthcare | 4.45% | $47.2M | $122.05B | 13.2 |
| 9 | TEVA | Teva Pharmaceutical Industries Ltd | Healthcare | 4.39% | $46.6M | — | — |
| 10 | H6D | Haleon PLC | Other | 3.95% | $42.0M | — | — |
| 11 | NVS | Novartis AG | Healthcare | 3.81% | $40.5M | $286.29B | 22.8 |
| 12 | ABBV | AbbVie Inc. | Healthcare | 3.81% | $40.5M | $504.37B | 80.6 |
| 13 | AZN | AstraZeneca PLC | Healthcare | 3.69% | $39.2M | — | — |
| 14 | JNJ | Johnson & Johnson | Healthcare | 3.38% | $35.9M | $615.87B | 38.8 |
| 15 | SNY | Sanofi | Healthcare | 3.18% | $33.8M | $97.31B | 21.4 |
| 16 | TAK | Takeda Pharmaceutical Company Limited | Healthcare | 2.90% | $30.8M | $62.84B | — |
| 17 | ZTS | Zoetis Inc. | Healthcare | 2.69% | $28.6M | $32.80B | 13.1 |
| 18 | VTRS | Viatris Inc. | Healthcare | 1.41% | $15.0M | $21.43B | — |
| 19 | JAZZ | Jazz Pharmaceuticals plc | Healthcare | 1.14% | $12.1M | $13.65B | 14.4 |
| 20 | CORT | Corcept Therapeutics Incorporated | Healthcare | 0.70% | $7.4M | $11.91B | 244.8 |
| 21 | AXSM | Axsome Therapeutics, Inc. | Healthcare | 0.56% | $6.0M | $8.23B | — |
| 22 | ELAN | Elanco Animal Health Incorporated | Healthcare | 0.46% | $4.9M | $11.76B | — |
| 23 | DFTX | Definium Therapeutics, Inc. | Healthcare | 0.42% | $4.5M | $4.31B | — |
| 24 | OGN | Organon & Co. | Healthcare | 0.28% | $3.0M | $3.61B | 17.6 |
| 25 | PRGO | Perrigo Company plc | Healthcare | 0.12% | $1.2M | $2.30B | — |
Weights as a percentage of net assets. Value held = weight × net assets ($1.06B). Market cap and P/E from each company's latest fundamentals (U.S.-listed stocks).
PPH sector breakdown
Sum of the weights of the holdings in each sector.
PPH top industries
PPH overlap with other ETFs
| ETF | Fund | Overlap | Shared holdings | Expense ratio |
|---|---|---|---|---|
| DIA | SPDR Dow Jones Industrial Average ETF | 4.8% | 2 of 30 | 0.16% |
| SPY | SPDR S&P 500 ETF | 4.4% | 10 of 502 | 0.09% |
| VTI | Vanguard Total Stock Market ETF | 4.1% | 16 of 2,941 | 0.03% |
| VXUS | Vanguard Total International Stock ETF | 0.9% | 4 of 8,035 | 0.05% |
| IWM | iShares Russell 2000 ETF | 0.2% | 2 of 1,962 | 0.19% |
| QQQ | Invesco QQQ ETF | 0.0% | 0 of 101 | 0.17% |
Overlap = sum over shared holdings of the smaller of the two weights. 100% means identical portfolios.
About the PPH portfolio
VanEck Pharmaceutical ETF holds 25 positions. The ten largest make up 72.1% of the fund, so it behaves like a portfolio of about 11 equally weighted stocks. The biggest positions are Eli Lilly and Company (21.83%), Merck & Co., Inc. (13.12%), Novo Nordisk A/S (5.49%), Pfizer Inc. (4.92%), McKesson Corporation (4.82%).
By sector, Healthcare is 96.7%, Other is 4.0%. Holdings data is from the fund's latest portfolio as reported by EODHD on October 25, 2026; positions change as the fund rebalances.
Related: PPH chart, PPH performance, PPH dividends, PPH valuation, PPH overview.
PPH holdings FAQ
How many holdings does PPH have?
PPH holds 25 positions as of October 25, 2026.
What are the top 10 holdings of PPH?
The ten largest holdings are Eli Lilly and Company (21.83%), Merck & Co., Inc. (13.12%), Novo Nordisk A/S (5.49%), Pfizer Inc. (4.92%), McKesson Corporation (4.82%), GSK plc (4.68%), Cencora (4.49%), Bristol-Myers Squibb Company (4.45%), Teva Pharmaceutical Industries Ltd (4.39%), Haleon PLC (3.95%). Together they are 72.1% of the fund.
What percentage of PPH is Eli Lilly and Company?
Eli Lilly and Company is the largest holding at 21.83% of net assets, about $231.8M of the fund's $1.06B.
How concentrated is PPH?
The top 10 holdings are 72.1% of the fund. By the effective number of holdings (1 divided by the sum of squared weights) PPH behaves like a portfolio of about 11 equally weighted stocks.